HIVIND

The antiretroviral roll out for HIV in India - strengthening capacity to promote adherence and patient follow-up in the context

 Coordinatore KAROLINSKA INSTITUTET 

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Ms.
Nome: Anna-Britta
Cognome: Karlsson
Email: send email
Telefono: +46 8 524 833 90

 Nazionalità Coordinatore Sweden [SE]
 Sito del progetto http://hivind.eu/
 Totale costo 3˙881˙494 €
 EC contributo 2˙946˙420 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-B
 Funding Scheme CP-SICA
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-11-01   -   2014-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Ms.
Nome: Anna-Britta
Cognome: Karlsson
Email: send email
Telefono: +46 8 524 833 90

SE (STOCKHOLM) coordinator 880˙333.00
2    CBCI Society for Medical Education

 Organization address address: St. John's National Academy of Health Sciences
city: Bangalore
postcode: 560034

contact info
Titolo: Prof.
Nome: Anura
Cognome: Kurpad
Email: send email
Telefono: 918026000000
Fax: 918026000000

IN (Bangalore) participant 889˙915.00
3    Y.R. GAITONDE MEDICAL EDUCATION & RESEARCH FOUNDATION

 Organization address address: "Rajiv Gandhi Salai, Taramani"
city: Chennai
postcode: 600113

contact info
Titolo: Mr.
Nome: Ak
Cognome: Ganesh
Email: send email
Telefono: 914423000000
Fax: 914423000000

IN (Chennai) participant 710˙073.00
4    TAMPEREEN YLIOPISTO

 Organization address address: Kalevantie 4
city: TAMPERE
postcode: 33014

contact info
Titolo: Prof.
Nome: Per
Cognome: Ashorn
Email: send email
Telefono: +358 3 3551 8410
Fax: 358336000000

FI (TAMPERE) participant 189˙688.00
5    CAVIDI AB

 Organization address city: Uppsala
postcode: 75183

contact info
Titolo: Dr.
Nome: Clas
Cognome: Kallander
Email: send email
Telefono: 4618552043
Fax: 4618552041

SE (Uppsala) participant 146˙408.00
6    Hanoi Medical University

 Organization address address: Ton That Tung- Dong Da 1
city: HANOI
postcode: 10000

contact info
Titolo: Prof.
Nome: Nguyen Duc
Cognome: Hinh
Email: send email
Telefono: 8448523798
Fax: 8448525115

VN (HANOI) participant 130˙003.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

antiretroviral    resistant    regimens    intervention    provinces    hiv    income    health    prevalence    affordable    public    load    first    line    epidemic    india    mobile    indian    patients    drug    patient    adherence    settings    implications    monitoring   

 Obiettivo del progetto (Objective)

'India is a nation of contrasts. The economy is modernizing, but the culture is traditional. Different provinces experience the HIV epidemic differently; even in high-prevalence areas, the epidemic reflects diverse social, cultural, religious, & sexual practices. This proposal focuses on 2 high prevalence provinces. As the antiretroviral (ART) program is scaled up, adherence is a key issue that needs to be addressed (as it is a key determinant of resistance, which has public health consequences). With limited affordable second-line regimens & restricted laboratory monitoring in low-income settings, optimal adherence to first-line regimens is essential. The study is a randomized controlled trial of an approach using a contextually relevant intervention (mobile telephones) to influence ART adherence in 600 ART naïve, HIV Indian patients eligible for ART, in Karnataka and Tamil Nadu. The conventional existing approach (as in the national guidelines) will be compared with an intervention in which the patient is provided adherence support using a mobile telephone interface. The study besides assessing the effect of intervention on adherence, will also provide data on the proportion of Indian patients failing first line ART. A study of factors associated with adherence, hitherto unstudied in India will be done. In addition the incidence and manifestations of opportunistic infections, immune reconstitution syndrome & adverse drug events will be described. The use of validated low-cost tests that optimize monitoring, are necessary here. Viral load is rarely used to monitor treatment because it is expensive. Instead falling CD4 counts are used. This usually occurs months/years after virological failure (increasing load); patients could have accumulated enough resistant mutations in this time to render other drugs useless. Using an affordable load test (evaluated in this study) will allow earlier detection of failure in this setting, thus having public health implications. Cost effectiveness will be studied. The project has policy implications for India and other low income settings.'

Introduzione (Teaser)

Better adherence of HIV-infected patients to antiretroviral therapy (ART) can improve outcomes and lower the risks of drug-resistant HIV strains emerging. Techniques to improve ART adherence and patient follow-up were investigated in south India.

Altri progetti dello stesso programma (FP7-HEALTH)

LACTOBODY (2008)

Production and delivery of antibody fragments against gastrointestinal pathogens by lactobacilli

Read More  

PROT-HISPRA (2011)

HIgh Speed PRoteomics Analysis (Prot-HiSPRA): Solving the bottlenecks of proteomics technologies for time sensitive proteome driven medical decisions

Read More  

MOODINFLAME (2008)

"Early diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system"

Read More